B2DG Events - 2008

Topic Speaker Title Company Datesort icon Location
B2DG is off for Holiday Recovery on Jan 3, 2012 . ' 01/03/2012 - 8:30am '
Future of Regulation of Genetic Information, Especially Whole Genome Sequencing Professor Hank Greely Chair of California’s Human Stem Cell Research Advisory Committee Stanford University 01/10/2012 - 6:00pm Wilson
NonClinical Safety Evaluation in Pharmaceutical Development Michael Taylor, Ph.D., DABT Non-Clinical Safety Assessment 01/17/2012 - 8:30am Sunnyvale
FDA’s 21 CFR 11 Inspection Assignments Angela Bazigos CEO Touchstone Technologies Silicon Valley 01/24/2012 - 8:30am Sunnyvale
Everything you always wanted to know about patents but were afraid to ask Nusrat Khaleeli Counsel Techlaw, LLP 01/31/2012 - 8:30am Sunnyvale
Children’s Global Health Initiative - A highlight of how researchers and clinicians at a local organizations are healing globally Seema Handu & Dr. Desiree LeBeaud Managing Director, assistant scientist at CHORI and a clinician at the Children’s Hospital in the Pediatric Infectious Disease Children's Global Health Initiative 02/07/2012 - 8:30am Sunnyvale
Challenges and Tips for Expanding Your Business into China Matt Levy President 55 Star Ventures 02/14/2012 - 6:00pm Wilson
Survive and Thrive: A Medical Imaging Device Start-Up Story Kendall Waters Silicon Valley Medical Instruments (SVMI) 02/21/2012 - 8:30am Fenwick
Developing Innovative Biotherapeutics driven by Unmet Medical Needs Xiaodong Yang, MD President & CEO Apexigen 02/28/2012 - 8:30am Fenwick
AlloMap: Changing Medical Practice and Revenue Pierre Cassigneul CEO & President XDx 03/06/2012 - 8:30am Sunnyvale
Reducing Maternal and Infant Mortality with a Solar Suitcase: The Power to Save Lives Laura Stachel, MD, MPH & Hal Aronson, PhD Co-Founders, Medical and Technology Directors WE CARE Solar 03/13/2012 - 6:00pm Wilson
Found in translation: new models for university/industry partnership David A. Shaywitz, MD, PhD, Director, Strategic and Commercial Planning Theravance, Inc. 03/20/2012 - 8:30am Sunnyvale
Next Generation Bioluminescent Probes: Ultrasensitive Biomarker Detection In Vivo and In Vitro Assays John Bashkin Vice President of Business Development Zymera 03/27/2012 - 8:30am Sunnyvale
Solving the Challenges of DNA Sequencing for Molecular Diagnostics Stefan Roever CEO & Founder Genia Technologies, Inc 04/03/2012 - 8:30am Sunnyvale
Dos and don'ts of preclinical medical device development James Swick, PhD Chief Scientific Officer LifeScience PLUS 04/10/2012 - 6:00pm Wilson
U.S. Supreme Court’s Prometheus Decision Further Defines the Scope of Patent Eligibility. What is the Impact on Personalized Medicine, Molecular Diagnostics and Human Gene Patents? Teresa Corbin and Pauline Farmer-Koppenol Partner, Intellectual Property & Litigation Groups and Associate, Intellectual Property Group respectively Fenwick & West 04/17/2012 - 8:30am Sunnyvale
Cell-Bonding Peptides and Biomimetic Implants Cheng Li, Ph.D. Consultant ' 04/24/2012 - 8:30am Sunnyvale
Treating Pancreatic Cancer with a Bacterial Vector: A Counter-Intiuitive Approach Stephen T. Isaacs Chairman, President and CEO Aduro BioTech 05/01/2012 - 8:30am Sunnyvale
Global Health: Building partnerships to enable local solutions to infectious disease and public health problems Eva Harris, PhD professor in the School of Public Health at UC Berkeley, Chair of the Center for Global Public Health and the founder and president of the Sustainable Sciences Institute UC Berkeley 05/08/2012 - 6:00pm Wilson
Topical Capsaicin for Pain Management: New Lessons From a Very Old Drug Keith Bley, Ph.D., . Solimar Therapeutics 05/15/2012 - 8:30am Sunnyvale
What Cancer Pathways Mean for the Biopharma Industry Ellen Licking Senior Editor and Analyst Value & Innovation LLC, a subsidiary of Real Endpoints 05/22/2012 - 8:30am Sunnyvale
An Interventional Device to prevent Heart Failure Karen Havenstrite & Ryan Krone Chief Scientific Officer (KH) & Lead Mechanical Engineer (RK) COR Innovations 05/29/2012 - 8:30am Sunnyvale
System Design Tools for Medical Devices and Life Science Instrumentation Giacomo Vacca, Ph. D. Founder and President Kinetic River Corporation 06/05/2012 - 8:30am Sunnyvale
Antibiotic Resistance: A Mounting Threat of Epidemic Proportions Dr. Deepti Jaggi Co-founder, President and Chief Medical Officer Vivonyx Inc. 06/12/2012 - 6:00pm Wilson
New FDA Draft Guidance for Clinical Data Standards Thamar Draper Senior Director, Professional Services and Product Management Omnicomm Systems 06/19/2012 - 8:30am Sunnyvale
Aging in Place: Achieving Extended Independence Through Virtual Social Networks, Device Monitoring and Technology Marc Bandt CEO Pelesend 06/26/2012 - 8:30am Sunnyvale